A more precise knowledge of HCV genotype distribution will be helpful to best inform national healthcare models to improve access to new treatments.
No takes yet. Share an insight, caveat, or question.
Petruzziello et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: